Approval · Notice of Compliance 21292 · 2018
AG-AZITHROMYCIN: Notice of Compliance 21292
Issued September 10, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21292
- Date
- September 10, 2018
- Company
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Canadian reference product
- ZITHROMAX (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AG-AZITHROMYCIN | 02480700 | Marketed |
| AG-AZITHROMYCIN | 02480719 | Dormant |
Medicinal ingredients
- AZITHROMYCIN DIHYDRATE 250 MG per TAB
- AZITHROMYCIN DIHYDRATE 600 MG per TAB